The drugs work by helping the brain transmit messages to nerves that control movement Nearly 1,000 people with advanced Parkinson's disease are to benefit from a new treatment that involves ...

The FDA has approved a new drug for Parkinson’s disease, giving the nod to Kyowa Kirin’s Nourianz (istadefylline) as an add-on to dopamine replacement drugs to reduce “off” episodes when ...

A recently published study found that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson's disease ...

Seamus Connolly, second from left, has become the first outpatient to begin ProDuodopa treatment for Parkinson's disease An NHS trust has become the first in the England to deliver a new treatment ...

A drug which has been used to treat liver disease for over 30 years is being trialled in patients with Parkinson’s Disease and will assess its potential to slow down disease progression for the first ...

Parkinson's drug, entacapone, induces iron deficiency, which alters the gut microbiome and triggers the growth of bacteria ...

In a groundbreaking new study scientists have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The ...

The data on medication management missteps for Parkinson's disease patients in the inpatient setting is "stunning," according ...

The error was only realised after the man was given two repeat prescriptions and complained of dizziness and imbalance.

A drug trial underway at Macquarie University is taking advantage of an early warning sign of Parkinson's in the hope of ...